UNIQA Insurance Group AG (UQA)
Prague Stock Exchange · Czech Republic · prices in CZK · close of 27 Oct 2026
Key indicators
| Last close | CZK 420.40 |
|---|---|
| 52-week range | 309.50 – 456.80 |
| Return, 1 month / 3 months | −8.0% / −0.9% |
| Return, 1 year / 3 years | +35.4% / +159.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 25.9% |
| Worst drawdown (1 year) | -13.0% |
| Average daily value traded | 0.01M CZK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
UNIQA Insurance Group is an Austrian insurance company based in Vienna. It provides life, health, property and casualty insurance to private individuals and corporate customers. The group serves customers across Austria and several countries in Central and Eastern Europe through its insurance and related financial services businesses. Its offerings include cover for homes, vehicles and personal health, along with savings and retirement products, sold through its own agents and partner channels.
UNIQA Insurance Group AG trades under the code UQA on the Prague Stock Exchange in Czech Republic, with its price quoted in Czech koruna (CZK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
UNIQA Insurance Group AG (UQA) trades on the Prague Stock Exchange in Czech Republic. It last closed at CZK 420.40 on 27 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 12 of 45 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.4% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Prague Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.6% | ||
| From 52-week high | -8.0% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | 8.4% | ||
| 12-month return, skipping the last month | 47.1% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.0% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M CZK | ||
| Zero-volume days | 36.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | −8.0% |
| 3 months | −0.9% |
| 6 months | +8.4% |
| 1 year | +35.4% |
| 3 years | +159.3% |
| 5 years | +164.7% |
Signals
| 50-day / 200-day average | 431.37 / 409.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.48 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Prague Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.